Fundraising FoxEpiEndo
Reykjavik, IS · 1 known investors
Find your way into EpiEndo
Sign up to find every way you can get introduced to EpiEndo
- Your email: who you already know at EpiEndo, and who your contacts know
- 2nd- and 3rd-degree connections: people you know who worked, studied or invested with the EpiEndo team
- Your LinkedIn: the connections who can make the intro for you
We rank every route by how warm it is, so you raise on warm intros instead of cold emails.
EpiEndo Pharmaceuticals is a clinical-stage biopharmaceutical company developing therapies for chronic respiratory diseases such as COPD, based on research into macrolides and their effects on the lung epithelium. Its lead program, EP395 (glasmacinal), is a non-antibacterial macrolide with anti-inflammatory activity that is Phase 2b ready.
Investors · 1
In the news
Frequently asked questions
- What does EpiEndo do?
- EpiEndo Pharmaceuticals is a clinical-stage biopharmaceutical company developing therapies for chronic respiratory diseases such as COPD, based on research into macrolides and their effects on the lung epithelium. Its lead program, EP395 (glasmacinal), is a non-antibacterial macrolide with anti-inflammatory activity that is Phase 2b ready.
- Who are EpiEndo's investors?
- EpiEndo's investors include Brunnur Ventures GP.
- Where is EpiEndo headquartered?
- EpiEndo is headquartered in Reykjavik, IS.